A US Patent application (application number 14/817063) co-authored by Arsénio Fialho from BSRG-iBB and by researchers from the University of Illinois headed by Prof. Ananda Chakrabarty has just been published. The innvention relates to compositions and methods of use of cupredoxins, and variants, derivatives and structural equivalents of cupredoxins that interfere with the ephrin signaling system in mammalian cells. Specifically, the invention relates to uses of cupredoxins, such as azurin, rusticyanin and plastocyanin, and variants, derivatives and structural equivalents thereof, to treat cancer in mammals. Click on title to learn more.
Photo: 3D model of Rusticyanin from Thiobacillus ferrooxidans.